News And Announcements
Smiths News inks long-term contract renewal with Financial Times
Newspaper distributor Smiths News has inked a long-term contract renewal with the Financial Times.
MJ Gleeson FY profits slide amid planning setbacks
Residential construction group MJ Gleeson said on Wednesday that planning setbacks had resulted in a significant profit decline for the year ended 30 June.
Reckitt said to have started talks on £6bn sale of homecare assets
Reckitt Benckiser has reportedly started early discussions with some of the potential suitors for its homecare assets, which could fetch more than £6bn in a deal.
Xaar swings to loss in challenging first half
Inkjet technology specialist Xaar reported interim revenue of £28. 6m on Wednesday, down from £34. 5m in the same period last year.
Software Circle makes several board changes
Software Circle announced significant changes to its board of directors on Wednesday, as it held its annual general meeting in Manchester.
Moonpig backs FY guidance, says trading in line
Online greeting card and gift retailer Moonpig backed its full-year guidance on Wednesday as it said trading has been in line with expectations.
PZ Cussons reports drop in full-year revenue, profit
Consumer goods company PZ Cussons reported a 10. 6% drop in full-year revenue to £527. 9m on Wednesday, primarily due to the significant devaluation of the Nigerian naira against sterling.
Arkle Resources reports progress across Botswana, Zimbabwe
Arkle Resources announced progress in its lithium exploration activities across Botswana and Zimbabwe in an update on Wednesday.
Semiconductor 'pioneer' Sehat Sutardja dies, says Alphawave
Alphawave IP Group said executive director Sehat Sutardja, which it described as “one of the pioneers” of the modern semiconductor industry, had died.
Supermarket Income REIT gives upbeat outlook as full-year profits rise
Grocery store investor Supermarket Income REIT hailed a resilient performance during its most recent financial year, growing rental income and profits despite ongoing macro challenges, as it delivered an optimistic outlook for the year ahead.
AstraZeneca's inflammatory disease drug Fasenra approved in the US
AstraZeneca has received the green light for its Fasenra drug in the US, used to treat patients with a rare inflammatory disease.
Segro prices €500m bond issue
Segro said it had priced €500m of senior unsecured bond issue for an eight-year term at 123 basis points above euro mid-swaps with an annual coupon of 3. 5%.